You are using an outdated browser. Please upgrade your browser to improve your experience.
Rush University Medical Center
Rush Cancer Center
1725 W. Harrison Street
Chicago, IL 60612
Direct phone: (312) 942-3047
Total transplants by cell source
- Marrow: 2
- PBSC: 55
- Cord Blood: 2
- Autologous (PBSC or Marrow): 136
About the center
The 30-bed, FACT-accredited, state-of-the-art unit offers patients the expertise of not only experienced transplant physicians, nurse practitioners and nurse clinicians, but also financial liaisons, pharmacists, radiation therapists, psychosocial oncologists, social workers, chaplains and nutritionists. Rush University Medical Center specializes in various types of transplantation, including: autologous transplantation; matched related and unrelated donor transplantation; haploidentical (half match related) donor transplant; and cord blood transplantation.
This center has been performing allogeneic transplants since 1984 and has been an NMDP/Be The Match transplant center since September 1993.
Adult - Sunita Nathan, Celalettin Ustun, Ankur Varma
Marrow/PBSC, single cord, and double cord
Cord blood transplants performed on
Other programs and services
Rush University Medical Center has made special arrangements with local hotels and housing to provide accommodations at reduced rates for BMT patients.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2018, 2019, 2020, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 84 patients.
The actual 1-year survival of these patients is 79.2%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 71.8% and 88.4%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2020 to December 31st, 2021 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2020 to December 31st, 2021 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
- U.S. Transplant Data by Center report at bloodcell.transplant.hrsa.gov
- List of diseases
Transplant center resources
Transplant center coordinator:
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)